StocksEditas Medicine IncEDIT

EDIT

Editas Medicine Inc

18.05 -0.47 (-2.54%)
Precios retrasados ofrecidos por el índice NASDAQ, en USD Mercado cerrado
Invertir
V
18.05
C
18.11
Publicación incluida
Genome Engineering
Vertex, Verve team up to develop a gene editing drug for liver disease 🔹 $VRTX (Vertex Pharmaceuticals Incorporated) is broadening its reach in gene editing, announcing Wednesday a deal with $VERV (Verve Therapeutics Inc) to develop a one-time treatment for an undisclosed liver disease. Vertex will... Mostrar más Traducir